Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

6.06

+0.19

(+3.24%)

At close: 04:00PM EDT

6.15

+0.09

(+1.49%)

After hours:

07:17PM EDT

Loading interactive chart...

GlobeNewswire
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting
NEEDHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present a poster at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting taking place November 6-10, 2024 in Houston, Texas and virtually. Presentation details are as follows: Title: Therapeutic potent
Simply Wall St.
Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30%
Key Insights The considerable ownership by individual investors in Candel Therapeutics indicates that they collectively...